Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A

Sun Pharmaceuticals Industries Ltd, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said.

http://in.reuters.com/article/2015/04/28/sun-pharm-m-a-idINKBN0NJ0AN20150428